ArticleScientific reports2026
Evaluation of the relationship between vitamin levels and symptom severity in adults with attention-deficit/hyperactivity disorder.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This cross-sectional study aimed to compare serum vitamin B12, 25-hydroxyvitamin D (25-OHD), ferritin, and iron levels between adults diagnosed with attention deficit hyperactivity disorder (ADHD) and healthy controls, and to evaluate the relationship between these biochemical markers and the severity of ADHD symptoms. In this cross-sectional study, a total of 35 adults with ADHD and 36 age- and sex-matched healthy controls who presented to a psychiatry outpatient clinic in Sakarya in 2024 were included. Participants' demographic data and clinical characteristics were collected through interviews, while laboratory findings were examined using blood samples taken at the time of inclusion in the study. The severity of ADHD symptoms was assessed using the Adult ADHD Self-Report Scale (ASRS) and the Wender-Utah Rating Scale (WURS). Serum vitamin B12 and 25-hydroxyvitamin D levels were significantly lower in the ADHD group compared with controls (p < 0.001). No significant differences were observed in ferritin and iron levels (p > 0.05). Vitamin B12 and 25-hydroxyvitamin D levels showed moderate-to-strong negative correlations with symptom severity. For example, vitamin B12 levels correlated with ASRS inattention (r = - 0.54, p = 0.00009) and WURS inattention (r = - 0.56, p = 0.000002), while 25-hydroxyvitamin D levels correlated with ASRS hyperactivity/impulsivity (r = - 0.53) and WURS depression (r = - 0.54). These findings indicate that lower serum vitamin B12 and 25-hydroxyvitamin D levels are associated with greater ADHD symptom severity in adults. The results underscore the potential relevance of biochemical factors in adult ADHD and suggest that assessment of vitamin status may be considered in future clinical and research contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.